ORYZON strengthens patent portfolio for iadademstat and vafidemstat with new Decisions to ... 16/09/2025 Healthcare Access to innovation Innovative drugs Oryzon Genomics S.A., a clinical-stage biopharmaceutical company and European leader in epigenetics, has strengthened... Partners - Oryzon Genomics
BCN HEALTH presents new analyses on hepatitis delta vs. hepatitis B healthcare costs in Sp... 16/09/2025 Healthcare Access to innovation BCN HEALTH participated in the European Association for the Study of the Liver (EASL) International Liver Congress (ILC... Partners - BCN Health
Farmadosis, a benchmark in pharmaceutical automation and safe medication management 15/09/2025 Healthcare Access to innovation With more than 20 years of experience, the Spanish company develops automation and digital solutions that enhance... Partners - BIOIB
World’s first foal born through maternal spindle transfer, an advanced assisted reproducti... 15/09/2025 Healthcare Access to innovation Embryotools, a biotechnology centre based at the Parc Científic de Barcelona (PCB), has achieved a new milestone in the... Partners - Parc Científic de Barcelona
Biohope presents the results of the BIOTRAIM study at the World Transplant Congress 2025: ... 16/09/2025 Healthcare Access to innovation In vitro diagnostics Immunobiogram® is a test that measures in vitro the sensitivity (response) of each patient's immune system cells to... Partners - Biohope
Sepsis causes up to 20,000 annual deaths in Spain: Biotechnology is revolutionizing early ... 13/09/2025 Healthcare Personalized medicine Viva In Vitro, an AseBio member, has developed VIVA-ELISA, a biotechnology tool that rapidly detects activation of the... AseBio - VIVA IN VITRO
Sepsis causes up to 20,000 annual deaths in Spain: Biotechnology is revolutionizing early ... 13/09/2025 VIVA IN VITRO At a global scale, according to WHO data, between 48 and 50 million cases are estimated each year, with at least 11... AseBio - VIVA IN VITRO
Life Sciences Strategy: Europe’s commitment to remain a global leader in health 10/09/2025 Healthcare Growing investment in R&D, eliminating unnecessary bureaucratic hurdles, and creating governance structures of its own... AseBio
Asabys Partners Leads €10 Million Extension of SafeHeal’s Oversubscribed Series C Financin... 10/09/2025 Healthcare Access to innovation Financing Asabys joins SafeHeal’s global investor syndicate, which includes Sofinnova, Solar Eclipse and a Leading Multinational... Partners - Asabys Partners
CONNECTA Therapeutics to Advance CTH120 into Phase II Pediatric Development for Fragile X ... 09/09/2025 Healthcare Access to innovation Financing CTH120 is a first-in-class neuroplasticity modulator with strong Phase I safety and tolerability data Partners - CONNECTA THERAPEUTICS
